JGP Global Gestao de Recursos’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-538
| Closed | -$383K | – | 48 |
|
|
2024
Q4 | $383K | Sell |
538
-1
| -0.2% | -$839 | 0.87% | 24 |
|
|
2024
Q3 | $567K | Buy |
539
+210
| +64% | +$234K | 1.11% | 15 |
|
|
2024
Q2 | $346K | Sell |
329
-4
| -1% | -$3.88K | 0.44% | 25 |
|
|
2024
Q1 | $321K | Sell |
333
-484
| -59% | -$460K | 0.21% | 32 |
|
|
2023
Q4 | $718K | Sell |
817
-2
| -0.2% | -$1.65K | 0.43% | 17 |
|
|
2023
Q3 | $674K | Sell |
819
-8
| -1% | -$6.29K | 0.43% | 20 |
|
|
2023
Q2 | $594K | Sell |
827
-7,932
| -91% | -$6.12M | 0.42% | 31 |
|
|
2023
Q1 | $357K | Buy |
8,759
+8,093
| +1,215% | +$6.1M | 0.37% | 33 |
|
|
2022
Q4 | $481K | Sell |
666
-2
| -0.3% | -$1.48K | 0.34% | 29 |
|
|
2022
Q3 | $460K | Buy |
668
+152
| +29% | +$95.7K | 0.39% | 24 |
|
|
2022
Q2 | $305K | Sell |
516
-4
| -0.8% | -$2.6K | 0.23% | 36 |
|
|
2022
Q1 | $363K | Sell |
520
-45
| -8% | -$28.5K | 0.21% | 41 |
|
|
2021
Q4 | $357K | Sell |
565
-1
| -0.2% | -$615 | 0.17% | 46 |
|
|
2021
Q3 | $343K | Sell |
566
-49
| -8% | -$30.4K | 0.12% | 55 |
|
|
2021
Q2 | $344K | Buy |
615
+2
| +0.3% | +$1.01K | 0.11% | 48 |
|
|
2021
Q1 | $290K | Sell |
613
-279
| -31% | -$136K | 0.18% | 44 |
|
|
2020
Q4 | $431K | Sell |
892
-3
| -0.3% | -$1.62K | 1.62% | 24 |
|
|
2020
Q3 | $501K | Sell |
895
-55
| -6% | -$33.3K | 0.27% | 29 |
|
|
2020
Q2 | $592K | Hold |
950
| – | – | 0.35% | 23 |
|
|
2020
Q1 | $464K | Sell |
950
-75
| -7% | -$30.9K | 0.2% | 33 |
|
|
2019
Q4 | $385K | Buy |
1,025
+12
| +1% | +$4.04K | 0.14% | 45 |
|
|
2019
Q3 | $281K | Buy |
1,013
+20
| +2% | +$5.92K | 0.16% | 51 |
|
|
2019
Q2 | $311K | Buy |
993
+387
| +64% | +$129K | 0.12% | 39 |
|
|
2019
Q1 | $249K | Buy |
606
+58
| +11% | +$23.9K | 0.09% | 52 |
|
|
2018
Q4 | $205K | Buy |
+548
| New | +$201K | 0.25% | 45 |
|
|
2017
Q3 | – | Sell |
-961
| Closed | -$472K | – | 33 |
|
|
2017
Q2 | $472K | Sell |
961
-218
| -18% | -$95.4K | 0.63% | 11 |
|
|
2017
Q1 | $457K | Sell |
1,179
-1,943
| -62% | -$720K | 0.38% | 11 |
|
|
2016
Q4 | $1.15M | Buy |
3,122
+828
| +36% | +$315K | 0.59% | 18 |
|
|
2016
Q3 | $922K | Buy |
2,294
+622
| +37% | +$250K | 0.09% | 19 |
|
|
2016
Q2 | $584K | Buy |
1,672
+31
| +2% | +$11.9K | 0.11% | 31 |
|
|
2016
Q1 | $591K | Buy |
+1,641
| New | +$676K | 0.25% | 29 |
|
Other funds holding REGN
JGP Global Gestao de Recursos's REGN Position: Q1 2025 in Review
JGP Global Gestao de Recursos sold out of Regeneron Pharmaceuticals (REGN) in Q1 2025, closing a stake of 538 shares — an estimated $383K sold.
JGP Global Gestao de Recursos first reported a position in REGN in Q1 2016 and held it in 31 quarters. The position peaked at $1.15M in Q4 2016. 1,290 funds tracked by Wall St. Rank hold REGN as of Q1 2025.
- JGP Global Gestao de Recursos reported no remaining Regeneron Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
- JGP Global Gestao de Recursos sold 538 Regeneron Pharmaceuticals shares in Q1 2025, an estimated $383K.
- JGP Global Gestao de Recursos first reported a position in Regeneron Pharmaceuticals in Q1 2016 and held it in 31 quarters.
- JGP Global Gestao de Recursos's Regeneron Pharmaceuticals position peaked at $1.15M in Q4 2016.
- 1,290 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2025.
Based on JGP Global Gestao de Recursos's 13F filing for Q1 2025, filed 9 May 2025.